You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

List of Excipients in API olanzapine


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing olanzapine

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Eli Lilly and Company ZYPREXA olanzapine 0002-4112 CARNAUBA WAX
Eli Lilly and Company ZYPREXA olanzapine 0002-4112 CELLULOSE, MICROCRYSTALLINE
Eli Lilly and Company ZYPREXA olanzapine 0002-4112 CROSPOVIDONE
Eli Lilly and Company ZYPREXA olanzapine 0002-4112 HYDROXYPROPYL CELLULOSE
Eli Lilly and Company ZYPREXA olanzapine 0002-4112 HYPROMELLOSE
Eli Lilly and Company ZYPREXA olanzapine 0002-4112 LACTOSE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Get Started Free

Excipients in ANDA-approved (generic) drugs containing olanzapine

Company Ingredient NDC Excipient
Teva Pharmaceuticals USA Inc olanzapine 0093-5245 ASPARTAME
Teva Pharmaceuticals USA Inc olanzapine 0093-5245 CELLULOSE, MICROCRYSTALLINE
Teva Pharmaceuticals USA Inc olanzapine 0093-5245 CROSPOVIDONE
Teva Pharmaceuticals USA Inc olanzapine 0093-5245 MAGNESIUM STEARATE
Teva Pharmaceuticals USA Inc olanzapine 0093-5245 MANNITOL
Teva Pharmaceuticals USA Inc olanzapine 0093-5245 SILICON DIOXIDE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for olanzapine

Excipient focus: ALCOHOL

Excipient focus: ALUMINUM OXIDE

Excipient focus: AMMONIA

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: ASPARTAME

Excipient focus: BENZYL ALCOHOL

Excipient focus: BUTYL ALCOHOL

Excipient focus: CARBOXYMETHYLCELLULOSE CALCIUM

Excipient focus: CARNAUBA WAX

Excipient focus: CARRAGEENAN

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CROSPOVIDONE

Excipient focus: D&C YELLOW NO. 10

Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE

Excipient focus: DIMETHICONE

Excipient focus: DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER

olanzapine drug variants not containing DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER

Company Ingredient NDC
Eli Lilly and Company olanzapine 0002-4112
Teva Pharmaceuticals USA Inc olanzapine 0093-5245
PAI Holdings LLC dba PAI Pharma olanzapine 0121-1072
Hikma Pharmaceuticals USA Inc olanzapine 0143-9199
Mylan Pharmaceuticals Inc olanzapine 0378-5510
American Regent Inc olanzapine 0517-0955
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 1 ALUMINUM LAKE

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C BLUE NO. 2--ALUMINUM LAKE

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: GELATIN

Excipient focus: GUAR GUM

Excipient focus: HYDROCHLORIC ACID

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: INDIGOTINDISULFONATE SODIUM

Excipient focus: LACTOSE

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: LECITHIN, SOYBEAN

Excipient focus: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MAGNESIUM SULFATE

Excipient focus: MALTODEXTRIN

Excipient focus: MANNITOL

Excipient focus: METHYL ALCOHOL

Excipient focus: ORANGE

Excipient focus: PECTIN

Excipient focus: PINEAPPLE

Excipient focus: POLACRILIN POTASSIUM

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 1000

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOL 8000

Excipient focus: POLYETHYLENE GLYCOLS

Excipient focus: POLYSORBATE 80

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SHELLAC

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM STEARYL FUMARATE

Excipient focus: SORBITOL

Excipient focus: STARCH, CORN

Excipient focus: SUCRALOSE

Excipient focus: TALC

Excipient focus: TARTARIC ACID

Excipient focus: TITANIUM DIOXIDE

olanzapine drug variants containing TITANIUM DIOXIDE

Company Ingredient NDC
Eli Lilly and Company olanzapine 0002-4112
NCS HealthCare of KY Inc dba Vangard Labs olanzapine 0615-7670
NCS HealthCare of KY Inc dba Vangard Labs olanzapine 0615-7673
NCS HealthCare of KY Inc dba Vangard Labs olanzapine 0615-7699
NCS HealthCare of KY LLC dba Vangard Labs olanzapine 0615-8243
Upsher-Smith Laboratories LLC olanzapine 0832-6078
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: TRIACETIN

Excipient focus: TRIETHYL CITRATE

Excipient focus: XANTHAN GUM

Excipient focus: XYLITOL

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links